These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 16500299)

  • 1. Preserved heart rate variability identifies low-risk patients with nonischemic dilated cardiomyopathy: results from the DEFINITE trial.
    Rashba EJ; Estes NA; Wang P; Schaechter A; Howard A; Zareba W; Couderc JP; Perkiomaki J; Levine J; Kadish A
    Heart Rhythm; 2006 Mar; 3(3):281-6. PubMed ID: 16500299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary prevention of sudden cardiac death in a nonischemic dilated cardiomyopathy population: reappraisal of the role of programmed ventricular stimulation.
    Gatzoulis KA; Vouliotis AI; Tsiachris D; Salourou M; Archontakis S; Dilaveris P; Gialernios T; Arsenos P; Karystinos G; Sideris S; Kallikazaros I; Stefanadis C
    Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):504-12. PubMed ID: 23588627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of heart rate variability to predict ventricular arrhythmias in recipients of prophylactic defibrillators with idiopathic dilated cardiomyopathy.
    Grimm W; Herzum I; Müller HH; Christ M
    Pacing Clin Electrophysiol; 2003 Jan; 26(1P2):411-5. PubMed ID: 12687856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Ponikowski P; Anker SD; Chua TP; Szelemej R; Piepoli M; Adamopoulos S; Webb-Peploe K; Harrington D; Banasiak W; Wrabec K; Coats AJ
    Am J Cardiol; 1997 Jun; 79(12):1645-50. PubMed ID: 9202356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arrhythmia risk stratification with regard to prophylactic implantable defibrillator therapy in patients with dilated cardiomyopathy. Results of MACAS, DEFINITE, and SCD-HeFT.
    Grimm W; Alter P; Maisch B
    Herz; 2004 May; 29(3):348-52. PubMed ID: 15167963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: results of the ALPHA Study.
    Salerno-Uriarte JA; De Ferrari GM; Klersy C; Pedretti RF; Tritto M; Sallusti L; Libero L; Pettinati G; Molon G; Curnis A; Occhetta E; Morandi F; Ferrero P; Accardi F;
    J Am Coll Cardiol; 2007 Nov; 50(19):1896-904. PubMed ID: 17980258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple autonomic and repolarization investigation of sudden cardiac death in dilated cardiomyopathy and controls.
    Pezawas T; Diedrich A; Winker R; Robertson D; Richter B; Wang L; Byrne DW; Schmidinger H
    Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1101-8. PubMed ID: 25262115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart rate variability in heart failure.
    Musialik-Łydka A; Sredniawa B; Pasyk S
    Kardiol Pol; 2003 Jan; 58(1):10-6. PubMed ID: 14502297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy.
    Kadish A; Dyer A; Daubert JP; Quigg R; Estes NA; Anderson KP; Calkins H; Hoch D; Goldberger J; Shalaby A; Sanders WE; Schaechter A; Levine JH;
    N Engl J Med; 2004 May; 350(21):2151-8. PubMed ID: 15152060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation between cardiac autonomic activity and compromise of left ventricular function in dilated cardiomyopathy].
    Hoffmann J; Grimm W; Menz V; Maisch B
    Z Kardiol; 2000 Feb; 89(2):84-92. PubMed ID: 10768276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trials of prophylactic implantable defibrillator therapy in patients with nonischemic cardiomyopathy: what have we learned and what can we expect from future trials?
    Grimm W
    Card Electrophysiol Rev; 2003 Dec; 7(4):463-7. PubMed ID: 15071276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart rate variability in patients suffering from structural heart disease and decreased AV-nodal conduction capacity. Insights into the formation of heart rate variability.
    Schwab JO; Eichner G; Schmitt H; Schrickel J; Yang A; Balta O; Lüderitz B; Lewalter T
    Z Kardiol; 2004 Mar; 93(3):229-33. PubMed ID: 15024591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [14-year experience with implantable cardioverter/defibrillators: determination of prognosis and discharge behavior].
    Vester EG; Dees H; Dobran I; Hennersdorf M; Perings C; Heydthausen M; Winter J; Strauer BE
    Z Kardiol; 2000; 89 Suppl 3():194-205. PubMed ID: 10810803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardioverter-defibrillator does not improve short-term survival among patients with non-ischemic cardiomyopathy and reduced left ventricular ejection fraction.
    Jilek C; Lewalter T; Pauschinger M; von Scheidt W; Frankenstein L; Pfister O; Hambrecht R; Bruder O; Brachmann J; Hartmann A; Strasser R; Hochadel M; Senges J
    Clin Res Cardiol; 2020 Jan; 109(1):115-123. PubMed ID: 31236690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Equivalent arrhythmic risk in patients recently diagnosed with dilated cardiomyopathy compared with patients diagnosed for 9 months or more.
    Makati KJ; Fish AE; England HH; Tighiouart H; Estes NA; Link MS
    Heart Rhythm; 2006 Apr; 3(4):397-403. PubMed ID: 16567284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost-effectiveness of primary prophylactic implantable defibrillator therapy in patients with ischaemic or non-ischaemic heart disease: a European analysis.
    Smith T; Jordaens L; Theuns DA; van Dessel PF; Wilde AA; Hunink MG
    Eur Heart J; 2013 Jan; 34(3):211-9. PubMed ID: 22584647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of Appropriate Shocks Using 24-Hour Holter Variables and T-Wave Alternans After First Implantable Cardioverter-Defibrillator Implantation in Patients With Ischemic or Nonischemic Cardiomyopathy.
    Seegers J; Bergau L; Expósito PM; Bauer A; Fischer TH; Lüthje L; Hasenfuß G; Friede T; Zabel M
    Am J Cardiol; 2016 Jul; 118(1):86-94. PubMed ID: 27189815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart rate variability and baroreflex sensitivity in idiopathic dilated cardiomyopathy.
    Hoffmann J; Grimm W; Menz V; Müller HH; Maisch B
    Heart; 2000 May; 83(5):531-8. PubMed ID: 10768902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.